Orange Book product · Brand (NDA)
ADREVIEW
IOBENGUANE SULFATE I-123
Brand (NDA)NDA 022290RX GE HEALTHCARE
At a glance
Sep 19, 2008
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 19, 2008
18 yr ago
Today
Pharmaceutical detail
Active ingredient
IOBENGUANE SULFATE I-123
Strength
10mCi/5ML (2mCi/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 022290
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
